| dbo:abstract |
JV-1-36 is a GHRH antagonist that has been shown to inhibit endometriotic cell proliferation and survival, suggesting that GHRH antagonist may represent promising tools for treatment of endometriosis. (en) |
| dbo:alternativeName |
Phenylacetyl-(D-Arg2·28,p-chloro-Phe6,Homoarg9·29,Tyr(Me)10,Abu15,Nle27)-Sermorelin (en) |
| dbo:iupacName |
N-(2-Phenylacetyl)-L-tyrosyl-D-arginyl-L-α-aspartyl-L-alanyl-L-isoleucyl-4-chloro-L-phenylalanyl-L-threonyl-L-asparaginyl-N6-(aminoiminomethyl)-L-lysyl-O-methyl-L-tyrosyl-L-arginyl-L-lysyl-L-valyl-L-leucyl-(2S)-2-aminobutanoyl-L-glutaminyl-L-leucyl-L-seryl-L-alanyl-L-arginyl-L-lysyl-L-leucyl-L-leucyl-L-glutaminyl-L-α-aspartyl-L-isoleucyl-L-norleucyl-D-arginyl-N6-(aminoiminomethyl)-L-lysinamide (en) |
| dbo:wikiPageID |
28199973 (xsd:integer) |
| dbo:wikiPageLength |
1755 (xsd:nonNegativeInteger) |
| dbo:wikiPageRevisionID |
1085623460 (xsd:integer) |
| dbo:wikiPageWikiLink |
dbr:Endometriosis dbc:Noninflammatory_disorders_of_female_genital_tract dbr:Endometriotic_cell dbr:GHRH_antagonist |
| dbp:iupacname |
N--L-tyrosyl-D-arginyl-L-α-aspartyl-L-alanyl-L-isoleucyl-4-chloro-L-phenylalanyl-L-threonyl-L-asparaginyl-N6--L-lysyl-O-methyl-L-tyrosyl-L-arginyl-L-lysyl-L-valyl-L-leucyl--2-aminobutanoyl-L-glutaminyl-L-leucyl-L-seryl-L-alanyl-L-arginyl-L-lysyl-L-leucyl-L-leucyl-L-glutaminyl-L-α-aspartyl-L-isoleucyl-L-norleucyl-D-arginyl-N6--L-lysinamide (en) |
| dbp:othernames |
Phenylacetyl--Sermorelin (en) |
| dbp:wikiPageUsesTemplate |
dbt:Chembox dbt:Chembox_Hazards dbt:Chembox_Identifiers dbt:Chembox_Properties dbt:Genito-urinary-drug-stub dbt:Reflist |
| dcterms:subject |
dbc:Noninflammatory_disorders_of_female_genital_tract |
| gold:hypernym |
dbr:Antagonist |
| rdf:type |
owl:Thing dul:ChemicalObject dbo:ChemicalSubstance wikidata:Q11173 yago:WikicatNoninflammatoryDisordersOfFemaleGenitalTract yago:Abstraction100002137 yago:Attribute100024264 yago:Condition113920835 yago:Disorder114052403 yago:PhysicalCondition114034177 dbo:ChemicalCompound dbo:Drug yago:State100024720 |
| rdfs:comment |
JV-1-36 is a GHRH antagonist that has been shown to inhibit endometriotic cell proliferation and survival, suggesting that GHRH antagonist may represent promising tools for treatment of endometriosis. (en) |
| rdfs:label |
JV-1-36 (en) |
| owl:sameAs |
freebase:JV-1-36 yago-res:JV-1-36 wikidata:JV-1-36 https://global.dbpedia.org/id/eg2W |
| prov:wasDerivedFrom |
wikipedia-en:JV-1-36?oldid=1085623460&ns=0 |
| foaf:isPrimaryTopicOf |
wikipedia-en:JV-1-36 |
| is dbo:wikiPageWikiLink of |
dbr:Glossary_of_chemical_formulae |
| is foaf:primaryTopic of |
wikipedia-en:JV-1-36 |